Iconovo (ICO) - Total Liabilities
Based on the latest financial reports, Iconovo (ICO) has total liabilities worth Skr15.48 Million SEK (≈ $1.67 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Iconovo - Total Liabilities Trend (2015–2025)
This chart illustrates how Iconovo's total liabilities have evolved over time, based on quarterly financial data. See Iconovo short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Iconovo Competitors by Total Liabilities
The table below lists competitors of Iconovo ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sarama Resources Ltd
AU:SRR
|
Australia | AU$1.95 Million |
|
KGW Group Berhad
KLSE:0282
|
Malaysia | RM21.81 Million |
|
Sahathai Terminal Public Company Limited
BK:PORT
|
Thailand | ฿1.74 Billion |
|
DB (International) Stock Brokers Limited
NSE:DBSTOCKBRO
|
India | Rs402.88 Million |
|
exax Inc
KQ:060230
|
Korea | ₩88.82 Billion |
|
The Motor & General Finance Limited
NSE:MOTOGENFIN
|
India | Rs843.31 Million |
|
Rocky Mountain Chocolate Factory
NASDAQ:RMCF
|
USA | $14.72 Million |
|
CMO Public Company Limited
BK:CMO
|
Thailand | ฿719.79 Million |
Liability Composition Analysis (2015–2025)
This chart breaks down Iconovo's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ICO stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.70 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.10 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.09 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Iconovo's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Iconovo (2015–2025)
The table below shows the annual total liabilities of Iconovo from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr13.16 Million ≈ $1.42 Million |
-20.10% |
| 2024-12-31 | Skr16.47 Million ≈ $1.77 Million |
+13.19% |
| 2023-12-31 | Skr14.55 Million ≈ $1.57 Million |
-54.48% |
| 2022-12-31 | Skr31.97 Million ≈ $3.44 Million |
+177.80% |
| 2021-12-31 | Skr11.51 Million ≈ $1.24 Million |
+38.41% |
| 2020-12-31 | Skr8.32 Million ≈ $894.85K |
+67.69% |
| 2019-12-31 | Skr4.96 Million ≈ $533.64K |
-43.11% |
| 2018-12-31 | Skr8.72 Million ≈ $937.94K |
-17.57% |
| 2017-12-31 | Skr10.57 Million ≈ $1.14 Million |
-7.06% |
| 2016-12-31 | Skr11.38 Million ≈ $1.22 Million |
+118.88% |
| 2015-12-31 | Skr5.20 Million ≈ $559.38K |
-- |
About Iconovo
Iconovo AB (publ) develops inhaled medicinal products in Sweden. The company offers ICOres, a multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler; and ICOone nasal single-dose dry powder inhaler for nasal use. It serves generic companies. The company has a collaboration agreeme… Read more